Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca2+-activated chloride channel

Hechen Wang1,2, Tianyu Wang2, Zeying Zhang1

  • 1Liaoning Provincial Key Laboratory of Oral Diseases, Department of Oromaxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, 117 Nanjing Bei Jie, Heping District, Shenyang,, 110002, Liaoning, China.

Abstract

Insights

High TMEM16A expression correlates with poor outcomes in oral squamous cell carcinoma (OSCC). Simvastatin inhibits OSCC cell proliferation by targeting TMEM16A, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Calcium-activated chloride channel TMEM16A is overexpressed in various cancers, including head and neck squamous cell carcinoma (HNSCC).
  • The specific role of TMEM16A in oral squamous cell carcinoma (OSCC) and the anti-tumor mechanisms of simvastatin are not fully understood.

Purpose of the Study:

  • To investigate the role of TMEM16A expression in OSCC.
  • To explore the anti-tumor effects of simvastatin on OSCC cells by targeting TMEM16A.

Main Methods:

  • Analysis of TMEM16A expression in human OSCC tissues using TCGA dataset and immunohistochemistry.
  • Cell proliferation assessed via CCK-8 assay.
  • TMEM16A chloride currents recorded using patch clamp technique.

Main Results:

  • High TMEM16A expression is associated with larger tumor size, lymph node metastasis, and poorer clinical outcomes in OSCC patients.
  • TMEM16A overexpression promotes OSCC cell proliferation; inhibiting TMEM16A suppresses proliferation.
  • Simvastatin inhibits TMEM16A channel activity and suppresses OSCC cell proliferation.

Conclusions:

  • Simvastatin exhibits anti-tumor effects in OSCC by targeting TMEM16A.
  • Targeting TMEM16A with simvastatin presents a potential novel therapeutic strategy for OSCC patients with high TMEM16A expression.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
946
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K